Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Össur - Executes on its Growth’27 strategy with the acquisition of FIOR & GENTZ

By Michael FriisHead of Equities
Embla Medical

Today, Össur announced an M&A transaction, as the company has acquired FIOR & GENTZ, a leading maker of lower limb neuro orthotic components. This is clearly in line with its Growth'27 strategy that includes M&A on top of organic growth and as a priority for capital allocation. 

For more details about the transaction, read here: https://view.news.eu.nasdaq.com/view?id=bf02fffe8f205c68bb226b23d231cf297&lang=en&src=listed

Together with Össur's CEO, we went through some of the transaction details, what they are buying, the strategic fit, and how this transaction will create value for shareholders.

Össur is a leading global provider of innovative mobility solutions in the medical technology space. Össur improves people’s mobility through the delivery of Prosthetics, Bracing & Supports, and accompanying Patient Care. Headquartered in Iceland, the company employs over 4,000 people located across 36 countries worldwide. Össur has extensive operations in the Americas, Europe, and Asia, as well as distributors in other markets.

Disclaimer: HC Andersen Capital receives payment from Össur for a Corporate Visibility/Digital IR subscription agreement. /Michael Friis, 17:30, 16 January 2024.

Recent videos

Luotea: A turnaround case with strong cash flow
16.04.2026 klo 10.52 Luotea
Dustin Group, Audiocast, Q2'26
15.04.2026 klo 10.30 Dustin Group
Carasent, Audiocast, Q1'26
14.04.2026 klo 09.00 Carasent
Revenio’s press conference on the Visionix acquisition
13.04.2026 klo 14.00 Revenio Group
Duell, Webcast, Q2'26
09.04.2026 klo 10.30 Duell
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.